Antineoplastic agents (№1357857)

Link to original

Publication date

Description

1. Section I. Contracting authority
   1. Name, addresses and contact point(s)
      Consejeria de Sanidad de la Comunidad de Madrid, Servicio Madrileño de Salud, Hospital Universitario de Mostoles
      Río Júcar, s/n
      Móstoles (Madrid)
      28935
      Spain
      Contact point(s): 28935
      For the attention of: Manuel Titos Machado
      Telephone: +34 916648697
      E-mail: [email protected]
      Fax: +34 916648784
      Internet address(es):
      Address of the buyer profile: http://madrid.org/contratospublicos
      Electronic access to information: http://madrid.org/contratospublicos
      
      
      
      
   2. Type of the contracting authority
      Regional or local authority
      
   3. Main activity
      Health
      
   4. Contract award on behalf of other contracting authorities
      The contracting authority is purchasing on behalf of other contracting authorities: yes
      Servicio Madrileño De Salud (Sermas)
      Plaza de Carlos Trías Beltrán, nº 7
      Madrid
      28020
      Spain
      Contact point(s): 28020
      
2. Section II. Object of the contract
   1. Description
      1. Title attributed to the contract by the contracting authority
         

         Medicamentos Oncológicos exclusivos.

      2. Type of contract and location of works, place of delivery or of performance
         Supplies
         Purchase
         Main site or location of works, place of delivery or of performance:

         Almacén de Farmacia del Hospital Universitario de Móstoles.

         NUTS code: ES3
         
      3. Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
         
      4. Short description of the contract or purchase(s)
         

         Adjudicación de Medicamentos Oncológicos exclusivos distribuidos en 16 lotes.

      5. Common procurement vocabulary (CPV):
         33652100
         
      6. Information about Government Procurement Agreement (GPA):
         The contract is covered by the Government Procurement Agreement (GPA): yes
         
   2. Total final value of contract(s):
      
      1. Total final value of contract(s):
         Value: 4 183 669.49 EUR
         Excluding VAT
         
4. Section IV. Procedure
   1. Type of procedure
      1. Type of procedure
         
   2. Award criteria
      1. Award criteria
         Lowest price
         
      2. Information about electronic auction
         An electronic auction will be used: no
         
   3. Administrative information
      1. File reference number attributed by the contracting authority
         

         A/SUM-000263/2017

      2. Previous publication(s) concerning the same contract
         
5. Section V. Award of contract
   Lot No: 1 - Lot title:

   Anagrelide 0,5 mg. Cápsulas (14 800 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Shire Pharmaceuticals Ibérica, S.L.
   av. Partenón, 16-18, 4ª planta
   Madrid
   28042
   Spain
   Contact point(s): 28042
   Telephone: +34 917904133
   E-mail: [email protected]
   Fax: +34 917904015
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 124 320.00 EUR
   Excluding VAT
   Total final value of the contract
   Value: 61 568.00 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 2 - Lot title:

   Azizatidina 100 mg. vial (268 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Celgene, S.L.
   Paseo de Recoletos, 37-39, 4ª planta
   Madrid
   28004
   Spain
   Contact point(s): 28004
   E-mail: [email protected]
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 162 013.24 EUR
   Excluding VAT
   Total final value of the contract
   Value: 80 235.13 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 3 - Lot title:

   Bevacizumab 1000 mg. vial (156 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Roche Farma, S.A.
   c/ Ribera del Loira, 50
   Madrid
   28042
   Spain
   Contact point(s): 28042
   Telephone: +34 916248100
   E-mail: [email protected]
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 85 972.07 EUR
   Excluding VAT
   Total final value of the contract
   Value: 42 576.64 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 4 - Lot title:

   Bevacizumab 400 mg. vial (312 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Roche Farma, S.A.U.
   c/ Ribera del Loira, 50
   Madrid
   28042
   Spain
   Contact point(s): 28042
   Telephone: +34 3248100
   E-mail: [email protected]
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 632 516.98 EUR
   Excluding VAT
   Total final value of the contract
   Value: 313 246.50 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 5 - Lot title:

   Bortezomib 3,5 mg. vial (200 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Janssen Cilag, S.A.
   Paseo Doce Estrellas, 5-7
   Madrid
   28042
   Spain
   Contact point(s): 28042
   Telephone: +34 917228080
   E-mail: [email protected]
   Fax: +34 917228516
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 371 019.60 EUR
   Excluding VAT
   Total final value of the contract
   Value: 183 743.04 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 6 - Lot title:

   Cetuximab 100 mg. vial (796 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Merck, S.L.
   c/ María de Molina, 40
   Madrid
   28006
   Spain
   Contact point(s): 28006
   Telephone: +34 917454435
   E-mail: [email protected]
   Fax: +34 917454444
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 279 859.27 EUR
   Excluding VAT
   Total final value of the contract
   Value: 138 596.97 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 7 - Lot title:

   Dasatinib 50 mg.Comprimido (672 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Bristol Myers Squibb, S.A.
   c/ Quintanavides, 15
   Madrid
   28050
   Spain
   Contact point(s): 28050
   Telephone: +34 914565440
   E-mail: [email protected]
   Fax: +34 914565497
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 77 426.06 EUR
   Excluding VAT
   Total final value of the contract
   Value: 36 949.04 EUR
   Including VAT
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 8 - Lot title:

   Enzalutamida 40 mg. cápsulas (9 744 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Astellas Pharma, S.A.
   Paseo del Club Deportivo, 1, bloque 14, 2ª
   Pozuelo de Alarcón
   28223
   Spain
   Contact point(s): 28223
   Telephone: +34 914952700
   E-mail: [email protected]
   Fax: +34 914952722
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 445 057.20 EUR
   Excluding VAT
   Total final value of the contract
   Value: 220 399.78 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 9 - Lot title:

   Paclitaxel Albumina 100 mg. vial. (440 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Celgene, S.L.
   Paseo de Recoletos, 37-39, 4ª planta
   Madrid
   28004
   Spain
   Contact point(s): 28004
   E-mail: [email protected]
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 192 822.82 EUR
   Excluding VAT
   Total final value of the contract
   Value: 95 491.97 EUR
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 10 - Lot title:

   Panitumumab 100 mg. vial (60 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Amgen, S.A.
   Moll de Barcelona, s/nº, edificio Sur 8ª planta
   Barcelona
   08039
   Spain
   Contact point(s): 08039
   Telephone: +34 936001900
   E-mail: [email protected]
   Fax: +34 936001988
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 42 102.90 EUR
   Excluding VAT
   Total final value of the contract
   Value: 20 850.96 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 11 - Lot title:

   Panitumumab 400 mg. vial (72 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Amgen, S.A.
   Moll de Barcelona, s/nº, edificio Sur 8ª planta
   Barcelona
   08039
   Spain
   Contact point(s): 08039
   Telephone: +34 936001900
   E-mail: [email protected]
   Fax: +34 936001988
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 202 092.41 EUR
   Excluding VAT
   Total final value of the contract
   Value: 100 083.86 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 12 - Lot title:

   Pozopanib 400 mg. comprimidos (2 160 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Novartis Farmacéutica, S.A.
   Gran vía de les Corts Catalanes, 764
   Barcelona
   08013
   Spain
   Contact point(s): 08013
   Telephone: +34 933064287
   E-mail: [email protected]
   Fax: +34 933062223
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 190 424.45 EUR
   Excluding VAT
   Total final value of the contract
   Value: 94 303.99 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 13 - Lot title:

   Pertuzumab 420 mg. vial (100 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Roche Farma, S.A.U.
   c/ Ribera del Loira, 50
   Madrid
   28042
   Spain
   Contact point(s): 28042
   Telephone: +34 913248100
   E-mail: [email protected]
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 462 310.80 EUR
   Excluding VAT
   Total final value of the contract
   Value: 228 953.92 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 14 - Lot title:

   Sorafenib 200 mg. comprimidos (4 032 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Bayer Hispania, S.L.
   av. Baix Llobregat, 3-5
   Sant Joan Despí, Barcelona
   08970
   Spain
   Contact point(s): 08970
   Telephone: +34 932284495
   E-mail: [email protected]
   Fax: +34 934956502
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 234 372.10 EUR
   Excluding VAT
   Total final value of the contract
   Value: 116 050.15 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 15 - Lot title:

   Trastuzumab 150 mg. vial (584 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 1
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Roche Farma, S.A.U.
   c/ Ribera del Loira, 50
   Madrid
   28042
   Spain
   Contact point(s): 28042
   Telephone: +34 913248100
   E-mail: [email protected]
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 621 833.86 EUR
   Excluding VAT
   Total final value of the contract
   Value: 307 955.81 EUR
   Including VAT
   If annual or monthly value
   Number of months: 12
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   Lot No: 16 - Lot title:

   Vinorelbina 30 mg. capsulas (452 UDS)

   1. Date of contract award decision
   25.04.2017
   2. Information about offers:
   Number of offers received: 0
   3. Name and address of economic operator in favour of whom the contract award decision has been taken:
   Lote Declarado Desierto, Debido a La Inexistencia de Ofertas
   
   4. Information on value of contract:
   Initial estimated total value of the contract
   Value: 59 525.76 EUR
   Excluding VAT
   5. Information about subcontracting
   The contract is likely to be sub-contracted: no
   
   
   
6. Section VI. Complementary information
   1. Information about European Union funds
      The contract is related to a project and/or programme financed by European Union funds: no
      
   2. Additional information
      
   3. Procedures for appeal
      1. Body responsible for appeal procedures
         Tribunal Administrativo de Contratación Pública
         carrera de San Jerónimo, 13, 1ª planta
         Madrid
         28013
         Spain
         Contact point(s): 28013
         Telephone: +34 917206346
         E-mail: [email protected]
         
      2. Lodging of appeals
         

         Contra el presente acto, que pone fin a la vía administrativa, podrá interponerse con carácter potestativo recurso especial en materia de contratación, anunciándolo previamente al órgano de contratación, en el plazo de 15 días hábiles contados desde el día siguiente a aquel en que se remita la notificación, ante el mismo órgano que lo ha dictado o ante el Tribunal Administrativo de Contratación Pública de la Comunidad de Madrid, o bien, directamente, recurso contencioso-administrativo en el plazo de 2 meses contados desde el día siguiente al de la recepción de la notificación, ante los Juzgados de lo Contencioso-Administrativo de Madrid, sin perjuicio de cualquier otro recurso que se estime procedente interponer. Todo ello conforme a lo dispuesto en los Artículos 40 y siguientes del RDL 3/2011, de 14 de Noviembre, por el que se aprueba el Texto Refundido de la Ley de Contratos del Sector Público; Artículos 123 y 124 de la Ley 39/2015, de 1 de octubre, del Procedimiento Administrativo Común de las Administraciones Públicas; y Artículos 8 al 12 de la Ley 29/1988, de 13 de julio, reguladora de la Jurisdicción Contencioso-Administrativa.

      3. Service from which information about the lodging of appeals may be obtained
         Servicio Jurídico del Hospital Universitario de Móstoles
         c/ Río Júcar, s/nº
         Móstoles
         28935
         Spain
         Contact point(s): 28935
         Telephone: +34 916648767
         E-mail: [email protected]
         
   4. Date of dispatch of this notice
      26.05.2017